Drug firm Hetero on Wednesday said it has launched generic oral antiviral drug Favipiravir used for the treatment of patients with mild to moderate COVID-19, in India under the brand name 'Favivir' at Rs 59 per tablet. The company has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI), Hetero said in a statement.from IndiaTV Business: Google News Feed https://ift.tt/3gfZcDi
0 Comments